SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-005726
Filing Date
2018-02-05
Accepted
2018-02-05 16:30:16
Documents
2
Period of Report
2018-02-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv484710_3.html 3  
1 OWNERSHIP DOCUMENT tv484710_3.xml 3 1590
2 EXHIBIT 24 tv484710_ex24.htm EX-24 3522
  Complete submission text file 0001144204-18-005726.txt   6895
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK NJ 07601
Business Address
Polverino Anthony J. (Reporting) CIK: 0001729957 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 18574566